[HTML][HTML] Combination CTLA-4 blockade and 4-1BB activation enhances tumor rejection by increasing T-cell infiltration, proliferation, and cytokine production

MA Curran, M Kim, W Montalvo, A Al-Shamkhani… - PloS one, 2011 - journals.plos.org
Background The co-inhibitory receptor Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4)
attenuates immune responses and prevent autoimmunity, however, tumors exploit this …

Combination CTLA-4 Blockade and 4-1BB Activation Enhances Tumor Rejection by Increasing T-Cell Infiltration, Proliferation, and Cytokine Production

MA Curran, M Kim, W Montalvo, A Al-Shamkhani… - PLoS ONE, 2011 - go.gale.com
Background The co-inhibitory receptor Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4)
attenuates immune responses and prevent autoimmunity, however, tumors exploit this …

Combination CTLA-4 blockade and 4-1BB activation enhances tumor rejection by increasing T-Cell infiltration, proliferation, and cytokine production

MA Curran, M Kim, W Montalvo, A Al-Shamkhani… - PLoS ONE, 2011 - eprints.soton.ac.uk
BACKGROUND: The co-inhibitory receptor Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4)
attenuates immune responses and prevent autoimmunity, however, tumors exploit this …

[HTML][HTML] Combination CTLA-4 Blockade and 4-1BB Activation Enhances Tumor Rejection by Increasing T-Cell Infiltration, Proliferation, and Cytokine Production

MA Curran, M Kim, W Montalvo, A Al-Shamkhani… - PLoS ONE, 2011 - ncbi.nlm.nih.gov
Background The co-inhibitory receptor Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4)
attenuates immune responses and prevent autoimmunity, however, tumors exploit this …

[PDF][PDF] Combination CTLA-4 Blockade and 4-1BB Activation Enhances Tumor Rejection by Increasing T-Cell Infiltration, Proliferation, and Cytokine Production

MA Curran, M Kim, W Montalvo, A Al-Shamkhani… - 2011 - academia.edu
Background: The co-inhibitory receptor Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4)
attenuates immune responses and prevent autoimmunity, however, tumors exploit this …

Combination CTLA-4 blockade and 4-1BB activation enhances tumor rejection by increasing T-cell infiltration, proliferation, and cytokine production.

MA Curran, M Kim, W Montalvo, A Al-Shamkhani… - Plos one, 2011 - europepmc.org
Background The co-inhibitory receptor Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4)
attenuates immune responses and prevent autoimmunity, however, tumors exploit this …

[PDF][PDF] Combination CTLA-4 Blockade and 4-1BB Activation Enhances Tumor Rejection by Increasing T-Cell Infiltration, Proliferation, and Cytokine Production

MA Curran, M Kim, W Montalvo, A Al-Shamkhani… - 2011 - researchgate.net
Background: The co-inhibitory receptor Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4)
attenuates immune responses and prevent autoimmunity, however, tumors exploit this …

Combination CTLA-4 blockade and 4-1BB activation enhances tumor rejection by increasing T-cell infiltration, proliferation, and cytokine production

MA Curran, M Kim, W Montalvo… - PloS …, 2011 - mdanderson.elsevierpure.com
Background: The co-inhibitory receptor Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4)
attenuates immune responses and prevent autoimmunity, however, tumors exploit this …

[引用][C] Combination CTLA-4 Blockade and 4-1BB Activation Enhances Tumor Rejection by Increasing T-Cell Infiltration, Proliferation, and Cytokine Production

MA Curran, M Kim, W Montalvo, A Al-Shamkhani… - PLoS …, 2011 - ui.adsabs.harvard.edu
Combination CTLA-4 Blockade and 4-1BB Activation Enhances Tumor Rejection by Increasing
T-Cell Infiltration, Proliferation, and Cytokine Production - NASA/ADS Now on home page ads …

[引用][C] Combination CTLA-4 Blockade and 4-1BB Activation Enhances Tumor Rejection by Increasing T-Cell Infiltration, Proliferation, and Cytokine Production

MA Curran, M Kim, W Montalvo, A Al-Shamkhani… - PLoS ONE, 2011 - cir.nii.ac.jp
Combination CTLA-4 Blockade and 4-1BB Activation Enhances Tumor Rejection by Increasing
T-Cell Infiltration, Proliferation, and Cytokine Production | CiNii Research CiNii 国立情報学 …